Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Board Meeting intimation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences has scheduled a Board meeting on 14th February 2026 to approve its un-audited standalone financial results for the quarter and nine months ended 31st December 2025. The Board will also consider the re-appointment of Mr. Sameer Goel (DIN: 00161786) as Managing Director for a further period of five years, from 29th March 2026 to 28th March 2031, subject to shareholder approval. His current tenure ends on 28th March 2026. The trading window for insiders remains closed until 16th February 2026.
Routine board agenda for quarterly results and leadership continuity. Re-appointment of the existing MD suggests stability in management with no leadership disruption expected.